SANA
NASDAQ · Biotechnology
Sana Biotechnology Inc
$3.27
-0.02 (-0.61%)
Open$3.31
Previous Close$3.29
Day High$3.32
Day Low$3.18
52W High$6.55
52W Low$1.60
Volume—
Avg Volume2.56M
Market Cap934.03M
P/E Ratio—
EPS$-0.98
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+1,125.7% upside
Current
$3.27
$3.27
Target
$40.08
$40.08
$23.55
$40.08 avg
$57.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 204.77M | 187.81M | 190.12M |
| Net Income | 17.06M | 14.80M | 14.99M |
| Profit Margin | 8.3% | 7.9% | 7.9% |
| EBITDA | 24.96M | 25.10M | 25.01M |
| Free Cash Flow | 20.72M | 16.56M | 17.82M |
| Rev Growth | +11.7% | +19.4% | -6.7% |
| Debt/Equity | 0.32 | 0.27 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |